Skip to content

TREO Abdominal Stent-Graft System 28-L2-11-100URecalls & reported problems

Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant

All models of TREO Abdominal Stent-Graft System (73)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08435761052050), received between Dec 5, 2024 and Dec 5, 2024 — classified as 2 injuries.

The most frequently reported specific device problem is “Device Stenosis” (2 reports).

1 other recall cover devices cleared under the same FDA submission (P190015); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 2 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Stenosis2

Patient problems

  • Stenosis2
  • Thrombosis/Thrombus2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 5, 2024Device Stenosis; Device Stenosis

    "(B)(6) HAD THEIR 3-YEAR FOLLOW-UP ON (B)(6)2024 AND RECENTLY DEVELOPED INCREASING CLAUDICATION SYMPTOMS ON THE RIGHT LEG THAT WERE DEBILITATING AND DIAGNOSED AS PROGRESSIVE EXTERNAL ILIAC OCCLUSIVE DISEASE. THE CT DATED (B)(6)2024 REFLECTED NO ENDOLEAKS, HOWEVER PER THE PI, THE CT "INDICATED THE ENDOGRAFT IN GOOD POSITION WITH SUCCESSFUL EXCLUSION OF ANEURYSM BUT THERE WAS A HIGH-GRADE STENOSIS OF THE OUTFLOW RIGHT EXTERNAL ILIAC ARTERY IN ITS PROXIMAL SEGMENT. THIS WAS FELT TO BE SEVERE AND COULD COMPROMISE FUNCTION IN THE GRAFT". ADDITIONALLY, THE STENOSIS "EXCEEDED 80% IF NOT 90%" POSING A RISK OF OCCLUSION WITH PROBABLE THROMBOSIS OF THE RIGHT LIMB OF THE GRAFT AND SEVERE ISCHEMIA. ON (B)(6)2024, THE SUBJECT UNDERWENT OUTPATIENT SURGERY INVOLVING AN ANGIOPLASTY WITH A 7MM BALLOON AND STENTING OF RIGHT EXTERNAL ILIAC ARTERY USING A 12X4 SMART STENT. THERE WERE NO COMPLICATIONS AND THE COMPLETION ANGIO REFLECTED THE RIGHT EXTERNAL ILIAC ARTERY AS WIDELY PATENT WITH NO RESIDUAL NARROWING." PATIENT OUTCOME: "THE SUBJECT WAS SEEN ON (B)(6)2024 AND HAD AN ULTRASOUND (US) ANKLE/BRACHIAL CONDUCTED SAME DAY REFLECTING AN IMPROVED ANKLE BRACHIAL INDEX (ABI) ON THE RIGHT SIDE AND NO FURT

    Patient problems: Stenosis; Thrombosis/Thrombus

    MAUDE report 20858394 ↗
  • InjuryDec 5, 2024Device Stenosis; Device Stenosis

    "SUBJECT (B)(6) HAD THEIR 3-YEAR FOLLOW-UP ON (B)(6) 2024 AND RECENTLY DEVELOPED INCREASING CLAUDICATION SYMPTOMS ON THE RIGHT LEG THAT WERE DEBILITATING AND DIAGNOSED AS PROGRESSIVE EXTERNAL ILIAC OCCLUSIVE DISEASE. THE CT DATED (B)(6) 2024 REFLECTED NO ENDOLEAKS, HOWEVER PER THE PI, THE CT "INDICATED THE ENDOGRAFT IN GOOD POSITION WITH SUCCESSFUL EXCLUSION OF ANEURYSM BUT THERE WAS A HIGH-GRADE STENOSIS OF THE OUTFLOW RIGHT EXTERNAL ILIAC ARTERY IN ITS PROXIMAL SEGMENT. THIS WAS FELT TO BE SEVERE AND COULD COMPROMISE FUNCTION IN THE GRAFT". ADDITIONALLY, THE STENOSIS "EXCEEDED 80% IF NOT 90%" POSING A RISK OF OCCLUSION WITH PROBABLE THROMBOSIS OF THE RIGHT LIMB OF THE GRAFT AND SEVERE ISCHEMIA. ON (B)(6) 2024, THE SUBJECT UNDERWENT OUTPATIENT SURGERY INVOLVING AN ANGIOPLASTY WITH A 7MM BALLOON AND STENTING OF RIGHT EXTERNAL ILIAC ARTERY USING A 12X4 SMART STENT. THERE WERE NO COMPLICATIONS AND THE COMPLETION ANGIO REFLECTED THE RIGHT EXTERNAL ILIAC ARTERY AS WIDELY PATENT WITH NO RESIDUAL NARROWING." PATIENT OUTCOME: "THE SUBJECT WAS SEEN ON (B)(6) 2024 AND HAD AN ULTRASOUND (US) ANKLE/BRACHIAL CONDUCTED SAME DAY REFLECTING AN IMPROVED ANKLE BRACHIAL INDEX (ABI) ON THE RIGHT SIDE

    Patient problems: Stenosis; Thrombosis/Thrombus

    MAUDE report 20857814 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P190015. One submission often covers many models, so check the product and lot details in each record.

  • Z-1689-2023 · May 3, 2023 · Open, Classified
    The TREO ABDOMINAL STENT-GRAFT SYSTEM (TREO) consists of four types of implants, specifically a Main Bifurcated Stent-Graft, a Leg Extension Stent-Graft, a Proximal Cuff Stent-Graf

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page